NCT06731803
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06731803
Title Platform Trial Evaluating Treatment of Neoadjuvant Trastuzumab-deruxtecan Containing Combination Therapies for HER2+, Resectable Esophagogastric Adenocarcinoma (NeoART)
Acronym NeoART
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Charite Universitätsmedizin Berlin NOT_YET_RECRUITING Berlin 13353 Germany Details
Klinikum Chemnitz gGmbH NOT_YET_RECRUITING Chemnitz 09116 Germany Details
Krankenhaus Nordwest GmbH Institut für Klinisch-Onkologische Forschung (IKF) NOT_YET_RECRUITING Frankfurt am Main 60488 Germany Details
Universitätsmedizin Halle, Universitätsklinikum Halle (Saale) NOT_YET_RECRUITING Halle 06120 Germany Details
Hämatologisch-Onkologische Praxis Eppendorf (hope) NOT_YET_RECRUITING Hamburg 20249 Germany Details
Nationales Centrum für Tumorerkrankungen NOT_YET_RECRUITING Heidelberg 69120 Germany Details
Universitätsklinikum Jena NOT_YET_RECRUITING Jena 07747 Germany Details
Universitätsklinikum Leipzig RECRUITING Leipzig 04103 Germany Details
Klinikum rechts der Isar München der TU München NOT_YET_RECRUITING München 81675 Germany Details
Klinikum Nürnberg NOT_YET_RECRUITING Nuremberg 90419 Germany Details
Universitätsklinikum Ulm NOT_YET_RECRUITING Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field